Showing results (591-600 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|December 28, 2020
Dissemination of Direct Healthcare Professional Communications on Medication Errors for Medicinal Products in the EU: An Explorative Study on Relevant FactorsChristina E Hoeve, Esther de Vries, Peter G M Mol, et al.
Drug Safety|August 27, 2022
A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety AnalysisUpinder Kaur, Anju K L, Mayank Chauhan, et al.
Drug Safety|November 12, 2021
Hybrid Method Incorporating a Rule-Based Approach and Deep Learning for Prescription Error PredictionSeunghee Lee, Jeongwon Shin, Hyeon Seong Kim, et al.
Drug Safety|September 6, 2022
High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk AssessmentJohannes M M Boots, Rogier A M Quax
Drug Safety|September 20, 2022
Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case-Control Study with a Focus on Medicines Used in Primary CareElizabeth E Roughead, Mhairi Kerr, Anna Moffat, et al.
Drug Safety|February 18, 2022
High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare DatabasesEtienne Volatier, Francesco Salvo, Antoine Pariente, et al.
Drug Safety|February 20, 2022
Impact of Preventive Strategies on Gastrointestinal Complications in Elderly Patients on Concomitant Use of Oral Anticoagulants and Nonsteroidal Anti-Inflammatory Drugs: A Nationwide Cohort StudySuhyun Lee, Kyu-Nam Heo, Mee Yeon Lee, et al.
Drug Safety|May 19, 2019
Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL StudyPaul K Winner, Andrew M Blumenfeld, Eric J Eross, et al.
Drug Safety|April 26, 2019
Mechanisms of Severe Cutaneous Adverse Reactions: Recent AdvancesTeresa Bellón
Drug Safety|August 19, 2018
Evaluation of Switching Patterns in FDA's Sentinel System: A New Tool to Assess Generic DrugsJoshua J Gagne, Jennifer R Popovic, Michael Nguyen, et al.
Pageof 308